ChemoCentryx, Inc. Recorded Big Gain
Tue, Nov 26, 2019 at 05:30 PM
ChemoCentryx, Inc. (CCXI:NASDAQ) soared at $30.73, representing a gain of 281.3%. On Mon 25 Nov 19, CCXI:NASDAQ hit a New 2-Week Intraday Low of $7.92. The stock got featured on our News Catalysts scanner on Tue 26 Nov 19 at 11:38 AM in the 'BIOTECH' category. From Tue 05 Nov 19, the stock recorded 28.57% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About ChemoCentryx, Inc. (CCXI:NASDAQ)
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 281.27%
- Baudax Bio, Inc. (BXRX:NASDAQ), 50.44%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 48.78%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 43.75%
- SG Blocks, Inc. (SGBX:NASDAQ), 29.62%
- China Ceramics Co., Ltd. (CCCL:NASDAQ), 29.17%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 28.69%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 26.98%
- Akerna Corp. (KERN:NASDAQ), 26.59%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 24.81%